S644 Pharmacokinetics and Local Tolerability of EP-104GI, an Extended-Release Formulation of Fluticasone Propionate for Treatment of Eosinophilic Esophagitis, After Intra-Esophageal Injection in Mini-Pigs

Murray Webb,Anastasia Litke,LIam MacFarlane,Amanda Malone
DOI: https://doi.org/10.14309/01.ajg.0001031944.76439.b6
2024-10-26
The American Journal of Gastroenterology
Abstract:EP-104GI is an extended-release formulation of Fluticasone Propionate (FP) in development for treatment of eosinophilic esophagitis. We report results from a 6-week study in mini-pigs comparing the pharmacokinetics, tissue distribution and local safety of intra-esophageal injection of EP-104GI with an oral gavage of an FP solution.
gastroenterology & hepatology
What problem does this paper attempt to address?